DB Biotech Ltd

DB Biotech was founded in 2006 by worldwide recognized experts in proteomics and immunology. The main focus of the company is on the design and production of clonal antibodies from crude rabbit antiserum with the highest specificity, affinity and avidity possible. Antibodies produced by DB Biotech are used for research, diagnostics, and treatment in areas of cancer, autoimmune disorders, neurological diseases, allergies, diabetes, and others. The main goal is to introduce a new standard for the application of antibodies on a daily basis, from background-free western blots, to special quantitative diagnostics, or potential applications of humanized antibodies for disease treatment purposes.

Products
We are offering a range of original monospecific antibodies especially designed for WB, ELISA, IP applications for basic research and IHC-P, IHC-Fr applications for routine use in clinical diagnostics. More about products.

New products
DB 1008 / Anti-Human Erk 1,2 FITC3.5.2012
DB 1508 / Anti-Human Erk 1,2, Unconjugated26.4.2012
DB 1509 / Anti-Human Phospho-Erk 1,2, Unconjugated26.4.2012

Services
One of our main activities is the custom design and production of monospecific rabbit clonal antibodies against any protein or its modification whose name, detailed description of the modification or amino-acid sequences are supplied by the project contractor.

Since 2011 our company has been providing highly sensitive / specific protein identification services with flexible and professional customer approach.

Technology
Our rabbit clonal antibodies are developed by a novel „in vitro cloning technology“ which enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes.

The obtained immunoglobulin recognizes one single linear epitope on the antigen molecule, therefore this antibody is comparable quality-wise to its monoclonal analogue.